1-9 of 9
Silvia Menendez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

Joan Albanell, José Manuel Pérez-García, Miguel Gil-Gil, Giuseppe Curigliano, Manuel Ruíz-Borrego, Laura Comerma, Joan Gibert, Meritxell Bellet, Begoña Bermejo, Lourdes Calvo, Juan de la Haba, Enrique Espinosa, Alessandro Marco Minisini, Vanesa Quiroga, Ana Santaballa Bertran, Leonardo Mina, Beatriz Bellosillo, Federico Rojo, Silvia Menéndez, Miguel Sampayo-Cordero, Crina Popa, Andrea Malfettone, Javier Cortés, Antonio Llombart-Cussac
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 67–80.
https://doi.org/10.1158/1078-0432.CCR-22-1281
Published: 04 January 2023
View article titled, Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
Open the PDF for Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial in another window
Includes: Supplementary data
Journal Articles

Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer

Cristina Guardia, Giampaolo Bianchini, Oriol Arpí-LLucià, Silvia Menendez, David Casadevall, Barbara Galbardi, Matteo Dugo, Sonia Servitja, Juan Carlos Montero, Luis Soria-Jiménez, MohammadA Sabbaghi, Raul Peña, Juan Madoz-Gúrpide, Belen Lloveras, Ana Lluch, Pilar Eroles, Joaquin Arribas, Atanasio Pandiella, Luca Gianni, Federico Rojo, Ana Rovira, Joan Albanell
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5096–5108.
https://doi.org/10.1158/1078-0432.CCR-20-2915
Published: 15 September 2021
View article titled, Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer
Open the PDF for Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve-Codina, Estela Pineda, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Raquel Lopez-Martos, Sonia Del Barco, Teresa Ribalta, Jaume Capellades, Josep Puig, Oscar Gallego, Carlos Mesia, Ana M Muñoz-Marmol, Ivan Archilla, Montserrat Arumí, Julie Marie Blanc, Beatriz Bellosillo, Silvia Menendez, Anna Esteve, Silvia Bagué, Ainhoa Hernandez, Jordi Craven-Bartle, Rafael Fuentes, Noemí Vidal, Iban Aldecoa, Nuria de la Iglesia, Carmen Balana
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (24): 6600–6609.
https://doi.org/10.1158/1078-0432.CCR-20-2171
Published: 15 December 2020
View article titled, Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
Open the PDF for Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation

Patricia Fernández-Nogueira, Mario Mancino, Gemma Fuster, Anna López-Plana, Patricia Jauregui, Vanesa Almendro, Estel Enreig, Silvia Menéndez, Federico Rojo, Aleix Noguera-Castells, Anke Bill, L. Alex Gaither, Laia Serrano, Leire Recalde-Percaz, Núria Moragas, Raul Alonso, Elisabet Ametller, Ana Rovira, Ana Lluch, Joan Albanell, Pere Gascon, Paloma Bragado
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1432–1448.
https://doi.org/10.1158/1078-0432.CCR-19-0353
Published: 13 March 2020
View article titled, Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Open the PDF for Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation in another window
Includes: Supplementary data
Journal Articles

NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

Aura Muntasell, Federico Rojo, Sonia Servitja, Carlota Rubio-Perez, Mariona Cabo, David Tamborero, Marcel Costa-García, María Martínez-Garcia, Sílvia Menéndez, Ivonne Vazquez, Ana Lluch, Abel Gonzalez-Perez, Ana Rovira, Miguel López-Botet, Joan Albanell
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (5): 1535–1545.
https://doi.org/10.1158/1078-0432.CCR-18-2365
Published: 01 March 2019
View article titled, NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
Open the PDF for NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival in another window
Includes: Supplementary data
Journal Articles

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

MohammadA Sabbaghi, Gabriel Gil-Gómez, Cristina Guardia, Sonia Servitja, Oriol Arpí, Sara García-Alonso, Silvia Menendez, Montserrat Arumi-Uria, Laia Serrano, Marta Salido, Aura Muntasell, Maria Martínez-García, Sandra Zazo, Cristina Chamizo, Paula González-Alonso, Juan Madoz-Gúrpide, Pilar Eroles, Joaquin Arribas, Ignasi Tusquets, Ana Lluch, Atanasio Pandiella, Federico Rojo, Ana Rovira, Joan Albanell
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 7006–7019.
https://doi.org/10.1158/1078-0432.CCR-17-0696
Published: 14 November 2017
View article titled, Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer
Open the PDF for Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

Israel Cañadas, Federico Rojo, Álvaro Taus, Oriol Arpí, Montserrat Arumí-Uría, Lara Pijuan, Silvia Menéndez, Sandra Zazo, Manuel Dómine, Marta Salido, Sergi Mojal, Antonio García de Herreros, Ana Rovira, Joan Albanell, Edurne Arriola
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (4): 938–950.
https://doi.org/10.1158/1078-0432.CCR-13-1330
Published: 16 February 2014
View article titled, Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
Open the PDF for Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Highly Efficient Gene Delivery for Bladder Cancers by Intravesically Administered Replication-Competent Retroviral Vectors

Eiji Kikuchi, Silvia Menendez, Choichiro Ozu, Makoto Ohori, Carlos Cordon-Cardo, Christopher R. Logg, Noriyuki Kasahara, Bernard H. Bochner
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4511–4518.
https://doi.org/10.1158/1078-0432.CCR-07-0151
Published: 01 August 2007
View article titled, Highly Efficient Gene Delivery for Bladder Cancers by Intravesically Administered Replication-Competent Retroviral Vectors
Open the PDF for Highly Efficient Gene Delivery for Bladder Cancers by Intravesically Administered Replication-Competent Retroviral Vectors in another window
Journal Articles

Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin

Eiji Kikuchi, Silvia Menendez, Makoto Ohori, Carlos Cordon-Cardo, Noriyuki Kasahara, Bernard H. Bochner
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (5): 1835–1842.
https://doi.org/10.1158/1078-0432.CCR-03-0099
Published: 10 March 2004
View article titled, Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin
Open the PDF for Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin in another window